Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$209.01 - $232.56 $31,978 - $35,581
-153 Reduced 10.53%
1,300 $283,000
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $18,187 - $20,910
92 Added 6.76%
1,453 $330,000
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $1,005 - $1,108
-5 Reduced 0.37%
1,361 $273,000
Q2 2023

Aug 10, 2023

BUY
$211.93 - $241.33 $7,417 - $8,446
35 Added 2.63%
1,366 $329,000
Q1 2023

May 11, 2023

SELL
$213.32 - $257.83 $42,237 - $51,050
-198 Reduced 12.95%
1,331 $305,000
Q4 2022

Feb 02, 2023

BUY
$203.72 - $248.97 $22,409 - $27,386
110 Added 7.75%
1,529 $359,000
Q3 2022

Nov 04, 2022

SELL
$204.81 - $262.19 $26,010 - $33,298
-127 Reduced 8.21%
1,419 $291,000
Q2 2022

Aug 01, 2022

SELL
$213.86 - $277.87 $45,766 - $59,464
-214 Reduced 12.16%
1,546 $362,000
Q1 2022

May 10, 2022

SELL
$259.82 - $298.18 $85,740 - $98,399
-330 Reduced 15.79%
1,760 $464,000
Q4 2021

Feb 08, 2022

BUY
$271.6 - $314.21 $49,702 - $57,500
183 Added 9.6%
2,090 $657,000
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $1,099 - $1,233
-4 Reduced 0.21%
1,907 $537,000
Q2 2021

Aug 12, 2021

BUY
$251.87 - $278.14 $3,022 - $3,337
12 Added 0.63%
1,911 $528,000
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $19,873 - $24,737
-97 Reduced 4.86%
1,899 $484,000
Q4 2020

Feb 09, 2021

SELL
$186.91 - $214.42 $6,168 - $7,075
-33 Reduced 1.63%
1,996 $406,000
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $82,846 - $99,844
-496 Reduced 19.64%
2,029 $382,000
Q2 2020

Aug 03, 2020

BUY
$113.31 - $182.44 $72,405 - $116,579
639 Added 33.88%
2,525 $419,000
Q1 2020

May 15, 2020

SELL
$104.32 - $195.28 $92,323 - $172,822
-885 Reduced 31.94%
1,886 $238,000
Q4 2019

Feb 18, 2020

BUY
$163.48 - $173.61 $51,005 - $54,166
312 Added 12.69%
2,771 $469,000
Q3 2019

Nov 12, 2019

SELL
$159.77 - $178.1 $61,191 - $68,212
-383 Reduced 13.48%
2,459 $413,000
Q2 2019

Aug 13, 2019

SELL
$144.16 - $172.9 $80,585 - $96,651
-559 Reduced 16.44%
2,842 $491,000
Q1 2019

May 15, 2019

BUY
$123.7 - $156.3 $29,688 - $37,512
240 Added 7.59%
3,401 $520,000
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $129,156 - $186,102
-1,069 Reduced 25.27%
3,161 $399,000
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $177,059 - $198,813
1,056 Added 33.27%
4,230 $735,000
Q2 2018

Aug 13, 2018

SELL
$160.33 - $189.41 $30,943 - $36,556
-193 Reduced 5.73%
3,174 $570,000
Q1 2018

May 14, 2018

SELL
$161.53 - $178.11 $21,321 - $23,510
-132 Reduced 3.77%
3,367 $545,000
Q4 2017

Feb 14, 2018

SELL
$147.99 - $163.95 $176,552 - $195,592
-1,193 Reduced 25.43%
3,499 $558,000
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $48,129 - $51,700
322 Added 7.37%
4,692 $708,000
Q2 2017

Aug 11, 2017

BUY
N/A
4,370
4,370 $674,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.